Sort by: after hours percent change | delayed percent change | gain open | gain high | gain close | publishing date
trial save search
89bio Reports Positive Topline Results from ENTRIGUE Phase 2 Trial of Pegozafermin in Patients with Severe Hypertriglyceridemia (SHTG)
Published: 2022-06-28 (Crawled : 01:00) - biospace.com/
ETNB | $3.55 3.2% -4.79% |
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
topline trial positive results
VBI Vaccines Announces New Long-Term Follow-Up Clinical Data for its 3-Antigen Adult Hepatitis B Vaccine Presented at EASL 2022
Published: 2022-06-28 (Crawled : 13:00) - biospace.com/
VBIV | $0.7945 -6.57% 0.69% |
|
Health Technology
|
| O: -6.85%
H: 1.74%
C: -7.07%
hepatitis for vaccine
Jazz Pharmaceuticals Announces Top-line Results from Phase 3 Trial Evaluating Nabiximols Oromucosal Spray in Adult Participants with Multiple Sclerosis Spasticity
Published: 2022-06-28 (Crawled : 12:00) - biospace.com/
JAZZ | $155.24 -0.93% 0.0% |
|
Health Technology
|
| O: 1.84%
H: 1.49%
C: -0.15%
trial results sclerosis
Jazz Pharmaceuticals Announces Top-line Results from Phase 3 Trial Evaluating Nabiximols Oromucosal Spray in Adult Participants with Multiple Sclerosis Spasticity
Published: 2022-06-28 (Crawled : 12:00) - prnewswire.com
JAZZ | $155.24 -0.93% 0.0% |
|
Health Technology
|
| O: 1.84%
H: 1.49%
C: -0.15%
trial results sclerosis
Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Synthetic Hypericin in the Treatment of Psoriasis
Published: 2022-06-28 (Crawled : 12:00) - prnewswire.com
SNGX | $0.5413 -2.28% -0.43% |
|
Health Technology
|
| O: 6.52%
H: 3.39%
C: -8.25%
treatment fda clearance for trial psoriasis
Global Clinical Trials Markets 2022-2028: Globalization of Clinical Trials / Increasing R&D Promoting Outsourcing / Adoption of New Technology in Clinical Research
Published: 2022-06-28 (Crawled : 11:00) - prnewswire.com
ICLR | $219.1 -0.81% 0.0% |
|
Health Technology
|
| O: 1.05%
H: 0.96%
C: -0.24%
LLY S | $317.62 -2.95% -0.47% |
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
NVO | $108.3 -4.07% -0.18% |
|
Health Technology
|
| O: -2.98%
H: 0.66%
C: -0.87%
trials research technology
APPS LOSS ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Digital Turbine, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - APPS
Published: 2022-06-27 (Crawled : 00:00) - prnewswire.com
APPS | $17.0 -3.46% 0.0% |
|
Technology Services
|
| O: -2.22%
H: 2.56%
C: -3.41%
trial deadline
Kezar Life Sciences Announces Positive Topline Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib for the Treatment of Patients with Lupus Nephritis
Published: 2022-06-27 (Crawled : 23:00) - biospace.com/
KZR M | $8.29 43.43% 0.12% |
|
Health Technology
|
| O: -1.99%
H: 2.96%
C: -2.36%
treatment sciences for topline lupus life trial positive results
RSKD FINAL DEADLINE FRIDAY: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Riskified Ltd. Investors with Losses to Secure Counsel Before Important July 1 Deadline in Securities Class Action - RSKD
Published: 2022-06-27 (Crawled : 18:00) - prnewswire.com
RSKD | $4.65 -2.52% 0.0% |
|
|
| O: -2.57%
H: 0.0%
C: 0.0%
trial trusted deadline
COVID-19 Vaccine Leaders Make Progress on Omicron-Specific Boosters
Published: 2022-06-27 (Crawled : 14:20) - biospace.com/
SNYNF | $108.84 4.15% |
|
Health Technology
|
| O: 4.15%
H: 0.0%
C: 0.0%
SNY | $52.14 -0.88% -0.38% |
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
covid-19 vaccine
Kiora Pharmaceuticals Receives Clinical Trial Approval for First-in-Human Evaluation of KIO-301 to Restore Vision in Patients with Retinitis Pigmentosa
Published: 2022-06-27 (Crawled : 14:00) - biospace.com/
KPRX | $0.4055 2.01% 1.11% |
|
Manufacturing
|
| O: 3.12%
H: 0.0%
C: -3.05%
kio-301 for trial approval
SELLAS Life Sciences Provides Clinical Update for GFH009 Ongoing Phase 1 Clinical Trial
Published: 2022-06-27 (Crawled : 14:00) - biospace.com/
SLS | $2.21 -4.74% 3.62% |
|
Health Technology
|
| O: 1.69%
H: 0.0%
C: -3.33%
gfh009 ongoing sciences for life trial update
Acer Therapeutics Announces Initiation of its Pivotal Phase 3 DiSCOVER Trial of EDSIVO™ (celiprolol) for the Treatment of Vascular Ehlers-Danlos Syndrome
Published: 2022-06-27 (Crawled : 13:20) - biospace.com/
ACER A | $1.36 -4.9% 0.0% |
|
Health Technology
|
| O: 1.64%
H: 29.84%
C: 15.32%
treatment for trial therapeutics
Adial Pharmaceuticals Announces Database Lock for the ONWARD™ Phase 3 Clinical Trial
Published: 2022-06-27 (Crawled : 13:20) - globenewswire.com
ADIL A | $1.12 -8.94% 0.89% |
|
Health Technology
|
| O: 9.24%
H: 0.0%
C: -5.38%
for trial
Cybin Receives FDA IND Clearance for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Potential Treatment of Major Depressive Disorder
Published: 2022-06-27 (Crawled : 13:00) - biospace.com/
CYBN | $0.578 -6.02% 0.0% |
|
n/a
|
| O: 0.44%
H: 8.47%
C: 4.24%
cyb003 treatment fda clearance for trial potential
Tonix Pharmaceuticals Announces Trial Design of New Phase 2 Clinical Study of TNX-1300 for Cocaine Intoxication
Published: 2022-06-27 (Crawled : 12:20) - biospace.com/
TNXP | $1.69 -4.52% 1.78% |
|
Health Technology
|
| O: -9.09%
H: 1.67%
C: -1.67%
tnx-1300 for trial
TG Therapeutics Announces Presentation of Exploratory Analyses from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis at the 8Th Congress of the European Academy of Neurology
Published: 2022-06-27 (Crawled : 12:00) - biospace.com/
TGTX | $4.06 -6.45% 2.96% |
|
Health Technology
|
| O: -7.94%
H: 0.0%
C: 0.0%
trials therapeutics presentation sclerosis
BridgeBio Pharma Announces Positive Phase 1 Data and Phase 2/3 Trial Design for BBP-711, a Potentially Best-In-Class GO Inhibitor for Primary Hyperoxaluria Type 1 (PH1) and Recurrent Kidney Stone Formers
Published: 2022-06-27 (Crawled : 12:00) - biospace.com/
BBIO A | $8.7 -6.85% 6.32% |
|
Health Technology
|
| O: 0.22%
H: 2.22%
C: 1.3%
bbp-711 pharma for kidney trial positive
Astellas Announces FDA Update on the FORTIS Clinical Trial of AT845 in Adults with Late-Onset Pompe Disease
Published: 2022-06-27 (Crawled : 08:00) - biospace.com/
ALPMY | $16.14 1.19% |
|
Manufacturing
|
| O: -1.2%
H: 0.0%
C: -0.37%
at845 fda disease trial update
Antengene Announces Clinical Trial Collaboration with BeiGene to Evaluate Selinexor in Combination with Tislelizumab in T and NK-Cell Lymphoma
Published: 2022-06-27 (Crawled : 01:00) - prnewswire.com
KPTI | $4.58 -8.95% 5.02% |
|
Health Technology
|
| O: -0.58%
H: 2.33%
C: -2.52%
collaboration trial
Your saved searches
Save your searches and get alerts when important news are released.
Mentioned Today
ABB | $26.87 -0.85% 0.82% |
|
Producer Manufacturing
ABLZF | $28.0 1.08% |
|
Producer Manufacturing
ACN | $283.8 -3.01% -0.99% |
|
Technology Services
AKAM | $92.39 -2.25% 0.5% |
|
Technology Services
ALPMF | $16.71 5.56% |
|
Health Technology
ALPMY | $16.14 1.19% |
|
Manufacturing
APH | $64.72 -2.12% 0.0% |
|
Electronic Technology
ARVL | $1.61 -4.73% 0.0% |
|
Manufacturing
BHC 4 | $8.83 1.73% -0.57% |
|
Health Technology
BNPQF | $49.65 -4.65% |
|
Finance
BNPQY | $24.99 -0.99% |
|
Finance and Insurance
BNPZY | $ 0% |
|
Finance and Insurance
BTG | $3.55 -3.01% 0.0% |
|
Non-Energy Minerals
CERN | $94.92 0.03% |
|
Technology Services
CGNT | $4.58 -28.66% 2.4% |
|
CGNX | $44.63 -1.85% -2.31% |
|
Electronic Technology
CLH | $87.8 0.92% 0.0% |
|
Industrial Services
COLD | $30.06 -0.76% 0.0% |
|
Finance
COP | $95.22 3.24% -0.2% |
|
Energy Minerals
CRCW | $0.965 1.58% |
|
Information
CREE | $80.07 0% |
|
Electronic Technology
CRM 4 | $171.46 -5.43% 0.13% |
|
Technology Services
CSCO | $43.06 -1.62% 0.09% |
|
Technology Services
CTXS | $96.15 -0.63% 0.0% |
|
Technology Services
CVLT | $63.29 -2.78% 0.0% |
|
Technology Services
CW | $131.15 -0.67% 0.0% |
|
Electronic Technology
DELL | $48.94 -2.59% 0.0% |
|
Electronic Technology
DGII | $23.3 -4.04% 0.0% |
|
Electronic Technology
DHR | $251.88 -1.77% 0.0% |
|
Health Technology
DKILF | $157.75 -5.18% |
|
Producer Manufacturing
DKILY | $16.18 0.81% |
|
Manufacturing
ECOM | $14.68 1.17% 4.97% |
|
Technology Services
ERIC | $7.78 -2.14% -0.39% |
|
Electronic Technology
ESLT | $210.38 1.14% 0.0% |
|
Electronic Technology
ETNB | $3.55 3.2% -4.79% |
|
Health Technology
EVH | $30.94 -2.74% 0.0% |
|
Commercial Services
FCN | $172.21 -1.22% 0.0% |
|
Commercial Services
FLIR | $57.34 0% |
|
Electronic Technology
GBERF | $546.0 |
|
Producer Manufacturing
GBERY | $48.7 -1.6% |
|
Manufacturing
GE | $65.88 -1.24% 0.47% |
|
Electronic Technology
GLAXF | $21.99 4.22% |
|
Health Technology
GLPI | $46.68 -0.09% -3.06% |
|
Finance
GSK | $43.35 -0.8% -0.09% |
|
Health Technology
GXO | $45.5 -1.22% 2.13% |
|
HNI | $35.65 -2.33% 0.0% |
|
Producer Manufacturing
HON | $175.95 -1.31% 0.03% |
|
Producer Manufacturing
HY | $33.35 -3.42% 0.0% |
|
Producer Manufacturing
IKTSF | $59.175 |
|
Commercial Services
IKTSY | $53.97 0.26% |
|
Professional, Scientific, and T...
INCY | $75.63 -2.24% -0.99% |
|
Health Technology
INTU 4 | $386.29 -4.55% 0.0% |
|
Technology Services
IRCP | $2.4984 0.06% |
|
Finance
JCI | $48.44 -0.43% 0.0% |
|
Producer Manufacturing
JTEKF | $ 0% |
|
Producer Manufacturing
JTEKY | $24.29 |
|
Manufacturing
LEA | $134.75 0.57% 0.0% |
|
Producer Manufacturing
LHX | $235.82 -0.42% 0.0% |
|
Electronic Technology
LLY 4 | $317.62 -2.95% -0.47% |
|
Health Technology
LMT | $420.71 0.35% 0.43% |
|
Electronic Technology
MASI | $137.07 -1.95% 0.0% |
|
Health Technology
MCFUF | $4.105 |
|
Technology Services
MCK 4 | $321.55 -1.44% -0.02% |
|
Distribution Services
MDRX 4 | $15.33 -2.23% 0.0% |
|
Technology Services
MDT | $89.2 -1.4% -0.1% |
|
Health Technology
MSFT | $256.48 -3.18% 0.06% |
|
Technology Services
MTX | $61.47 -0.87% 0.0% |
|
Process Industries
NDAQ 4 | $154.66 -2.07% -1.61% |
|
Finance
NIO | $22.36 -2.57% -6.66% |
|
Consumer Durables
NIPNF | $38.0 |
|
Technology Services
NOC | $464.67 -0.46% 0.74% |
|
Electronic Technology
NUVB | $3.55 -2.47% 0.0% |
|
NVS | $84.17 -1.3% 0.12% |
|
Health Technology
NVSEF | $84.85 1.0% |
|
Health Technology
ORCL 4 | $68.58 -2.6% 1.43% |
|
Technology Services
PCRFF | $8.217 0.82% |
|
n/a
PCRFY | $8.16 -0.73% |
|
n/a
PPRUF | $544.41 1.95% |
|
Consumer Non-Durables
PPRUY | $52.31 0.13% |
|
Manufacturing
RELX | $26.77 -1.91% 0.19% |
|
Commercial Services
RLXXF | $26.94 -1.93% |
|
Commercial Services
RNGR | $10.28 -0.48% 0.0% |
|
Industrial Services
ROK | $197.64 -1.82% 0.0% |
|
Producer Manufacturing
RSG 4 | $127.91 -1.15% 0.0% |
|
Industrial Services
RYLPF | $21.425 -2.83% |
|
Health Technology
SAP | $95.47 -1.88% -0.49% |
|
Technology Services
SAPGF | $97.382 -1.0% |
|
Technology Services
SBGSF | $124.59 -1.9% |
|
Producer Manufacturing
SBGSY | $24.426 -0.99% |
|
Manufacturing
SEKEF | $15.184 -6.47% |
|
Electronic Technology
SEKEY | $7.34 -0.74% |
|
Manufacturing
SNNUF | $15.05 4.44% |
|
Health Technology
TEL | $114.92 -2.24% 0.0% |
|
Electronic Technology
TEVJF | $8.34 0.48% |
|
Health Technology
TMO | $535.77 -1.45% -1.84% |
|
Health Technology
TRI | $101.23 -2.95% 0.0% |
|
Commercial Services
UL | $45.33 -1.46% 0.0% |
|
Consumer Non-Durables
UNLYF | $45.805 -3.0% |
|
Consumer Non-Durables
VEON | $0.4567 -0.74% 0.42% |
|
Communications
VMW | $116.25 -1.2% 0.0% |
|
Technology Services
VSH | $18.22 -0.92% 0.0% |
|
Electronic Technology
VTRS | $10.9 -1.54% 1.19% |
|
Health Technology
WFC 4 | $40.18 -0.15% 0.25% |
|
Finance
WKEY | $2.68 -5.63% 2.24% |
|
Technology Services
WM | $148.88 -0.43% -0.08% |
|
Industrial Services
XYL 4 | $77.9 -2.07% 0.0% |
|
Producer Manufacturing
ZTS 4 | $170.12 -2.01% 0.96% |
|
Health Technology
ZUO 4 | $9.3 -5.3% 0.0% |
|
Technology Services